CA Sansaar
RBI Defers UTI Rollout for OTC Derivatives to 2027
Print
The Reserve Bank of India (RBI) has decided to postpone the mandatory implementation of the Unique Transaction Identifier (UTI) framework for over-the-counter (OTC) derivative transactions. The revised implementation date has now been extended to January 1, 2027, allowing regulators additional time to streamline reporting mechanisms and obtain a more consolidated and transparent view of the derivatives market.
Currently, all OTC transactions relating to rupee interest rate derivatives, government securities forward contracts, foreign currency derivatives, foreign currency interest rate derivatives, and credit derivatives are reported to the Trade Repository operated by Clearing Corporation of India Limited (CCIL-TR). To further strengthen oversight and improve traceability, RBI has mandated that each OTC derivative contract must be assigned a Unique Transaction Identifier.
The UTI system is designed to assign a single, standardized reference number to every OTC derivative transaction. This helps regulators track transactions efficiently, avoid duplication, enhance data accuracy, and monitor systemic risk more effectively. The initiative aligns India’s reporting framework with established international standards followed in major global financial markets.
Earlier, RBI had proposed implementing the UTI requirement by April 2026, as mentioned in its draft circular. However, after reviewing industry feedback and assessing operational preparedness, the regulator has extended the timeline. The new directions will apply to all eligible OTC derivative transactions executed on or after January 1, 2027.
This move reflects RBI’s calibrated approach toward strengthening financial market infrastructure while ensuring that market participants receive sufficient time to upgrade systems and comply with the enhanced reporting standards.
Currently, all OTC transactions relating to rupee interest rate derivatives, government securities forward contracts, foreign currency derivatives, foreign currency interest rate derivatives, and credit derivatives are reported to the Trade Repository operated by Clearing Corporation of India Limited (CCIL-TR). To further strengthen oversight and improve traceability, RBI has mandated that each OTC derivative contract must be assigned a Unique Transaction Identifier.
The UTI system is designed to assign a single, standardized reference number to every OTC derivative transaction. This helps regulators track transactions efficiently, avoid duplication, enhance data accuracy, and monitor systemic risk more effectively. The initiative aligns India’s reporting framework with established international standards followed in major global financial markets.
Earlier, RBI had proposed implementing the UTI requirement by April 2026, as mentioned in its draft circular. However, after reviewing industry feedback and assessing operational preparedness, the regulator has extended the timeline. The new directions will apply to all eligible OTC derivative transactions executed on or after January 1, 2027.
This move reflects RBI’s calibrated approach toward strengthening financial market infrastructure while ensuring that market participants receive sufficient time to upgrade systems and comply with the enhanced reporting standards.
Category : RBI | Comments : 0 | Hits : 356
Comments